| Application no. and date | 23160271.5 (espacenet) (Federated) (European Patent Register), 20191127 | | Patent/reg. no. and date | DK/EP 4233850, 20241002 | | Publication date | 20230830 | | Priority no. and date | US 201862773848 P, 20181130 | | EP pub. no. and date |
EP 4233850 20230830 | | Effective date | | | Applicant/owner | ChemoCentryx, Inc., One Amgen Center Drive
Thousand Oaks, CA 91320, US | | Applicant ref. no. | V485581DK00 | | Inventor | LELETI, Manmohan Reddy,
California, 94568, US,
POWERS, Jay P,
California, 94044, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/451 (2006.01) , A61K 47/10 (2017.01) , A61K 47/14 (2017.01) , A61K 47/40 (2006.01) , A61K 47/44 (2017.01) , A61K 9/48 (2006.01) , A61P 29/00 (2006.01) | | Title | Kapselformuleringer | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
